联系客服

002038 深市 双鹭药业


首页 公告 双鹭药业:2020年半年度财务报告

双鹭药业:2020年半年度财务报告

公告日期:2020-08-26

双鹭药业:2020年半年度财务报告 PDF查看PDF原文
北京双鹭药业股份有限公司
 2020 年半年度财务报告


            北京双鹭药业股份有限公司

                财务报表及报表附注

            (2020 年 1 月 1 日至 2020 年 06 月 30 日止)

                      目    录                    页 次
一、  财务报表

      合并资产负债表                                  1-2
      合并利润表                                        3
      合并现金流量表                                    4
      合并股东权益变动表                              5-6
      母公司资产负债表                                7-8
      母公司利润表                                      9
      母公司现金流量表                                  10
      母公司股东权益变动表                          11-12
      财务报表附注                                    1-86

                          合并资产负债表

                                                2020/6/30

编制单位:北京双鹭药业股份有限公司                                (除特别注明外,金额单位均为人民币元)
                      资 产                          附注六          期末余额            期初余额

流动资产:

 货币资金                                            注释1          933,238,213.74      1,260,863,772.22
 以公允价值计量且其变动计入当期损益的金融资产

 交易性金融资产                                      注释2          146,944,150.79      140,450,033.61
 衍生金融资产
 应收票据

 应收账款                                            注释3          529,432,773.87      603,837,203.61
 应收款项融资                                        注释4          18,493,496.12        40,390,372.11
 预付款项                                            注释5          268,483,292.49      196,753,485.09
 其他应收款                                          注释6              273,734.92          263,454.87
 存货                                                注释7          118,257,798.19      108,345,829.53
 应收股利
 一年内到期的非流动资产

 其他流动资产                                        注释8          408,149,495.85      514,437,555.14
流动资产合计                                                      2,423,272,955.97      2,865,341,706.18
非流动资产:
 可供出售金融资产
 持有至到期投资
 债权投资
 其他债权投资
 长期应收款

 长期股权投资                                        注释9          914,526,344.67      408,680,545.37
 其他权益工具投资

 其他非流动金融资产                                      注释10        266,182,482.04      179,696,744.83
 投资性房地产                                        注释11          17,252,177.64        17,705,041.14
 固定资产                                                注释12        517,416,221.92      478,803,970.85
 在建工程                                                注释13          60,256,498.76      109,155,304.40
 生产性生物资产
 油气资产

 无形资产                                                注释14        386,608,046.12      407,429,583.23
 开发支出                                                注释15        248,206,914.18      233,748,718.65
 商誉
 长期待摊费用

 递延所得税资产                                      注释16          21,429,104.93        22,622,950.91
 其他非流动资产                                      注释17        553,188,548.64      501,781,612.29
非流动资产合计                                                    2,985,066,338.90      2,359,624,471.67
资产总计                                                          5,408,339,294.87      5,224,966,177.85

(后附财务报表附注为合并财务报表的组成部分)

 企业法定代表人:徐明波              主管会计工作负责人: 李亚军              会计机构负责人:冀莉


                      合并资产负债表(续)

                                                2020/6/30

编制单位:北京双鹭药业股份有限公司                                (除特别注明外,金额单位均为人民币元)
                负债和股东权益                      附注六          期末余额            期初余额

流动负债:

 短期借款                                            注释18            5,598,300.00          3,935,927.38
 以公允价值计量且其变动计入当期损益的金融负债
 交易性金融负债
 衍生金融负债
 应付票据

 应付账款                                            注释19        175,323,602.22      178,505,820.02
 预收款项                                            注释20          12,339,328.08        14,214,586.30
 应付职工薪酬                                        注释21          12,572,433.58        11,641,349.71
 应交税费                                            注释22          16,565,763.31        25,849,787.05
 其他应付款                                          注释23          93,472,637.91        98,487,006.64
 持有待售负债
 一年内到期的非流动负债
 其他流动负债

流动负债合计                                                        315,872,065.10      332,634,477.10
非流动负债:
 长期借款
 应付债券

    其中:优先股

    其中:永续债
 长期应付款
 长期应付职工薪酬
 预计负债

 递延收益                                            注释24          58,312,772.38        65,263,516.76
 递延所得税负债                                      注释16          20,378,686.13          5,859,013.94
 其他非流动负债

非流动负债合计                                                        78,691,458.51        71,122,530.70
负债合计                                                            394,563,523.61      403,757,007.80
股东权益:

 股本                                                注释25        1,027,350,000.00      1,027,350,000.00
 其他权益工具

    其中:优先股

    其中:永续债

 资本公积                                            注释26            7,473,743.19          7,473,743.19
 减:库存股

 其他综合收益                                        注释27          -11,650,889.22        -8,733,865.37
 专项储备

 盈余公积                                            注释28        598,028,763.52
[点击查看PDF原文]